Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant

Despite the effectiveness of the currently available antiviral drugs in treating cytomegalovirus (CMV) infection, high rates of adverse effects are associated with their use. Moreover, a problem of increasing importance is the emergence of drug-resistant CMV infection. Here, we describe the first ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiereghin, Angela, Belotti, Tamara, Borgatti, Eva Caterina, Fraccascia, Nicola, Piccirilli, Giulia, Fois, Maura, Borghi, Michele, Turello, Gabriele, Gabrielli, Liliana, Masetti, Riccardo, Prete, Arcangelo, Fanti, Stefano, Lazzarotto, Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001039/
https://www.ncbi.nlm.nih.gov/pubmed/33790588
http://dx.doi.org/10.2147/IDR.S296927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001039/
https://www.ncbi.nlm.nih.gov/pubmed/33790588
http://dx.doi.org/10.2147/IDR.S296927

Ejemplares similares